What does CPTC mean in CANCER

CPTC is an initiative powered by the NCI to develop, validate, and apply innovative proteomic technologies for cancer research and care. It combines powerful new technologies with existing knowledge to uncover novel information about cancer biology and facilitate the development of personalized treatments and approaches to early detection of cancer.

The primary goals of CPTC are to advance understanding of fundamental mechanisms underlying cancer pathogenesis, identification of additional molecular targets useful for diagnosis and treatment interventions, elucidation of modifiable risk factors related to individual tumor characteristics, discovery or validation of biomarkers associated with clinical endpoints such as response to treatment or disease progression, development or validation of assays that measure mechanistically aligned biomarkers in multi-analyte platforms, as well as application these technologies in a clinical setting.

CPTC utilizes existing knowledge by combining it with powerful new technologies which help uncover novel information about cancer biology. This is done in order to facilitate the development of personalized treatments and approaches for early detection.

CPTC advances understanding through its goal to identify additional molecular targets useful for diagnosis and treatment interventions as well as elucidating modifiable risk factors related to individual tumor characteristics. All this information helps inform medical professionals on potential effective treatments they can utilize on patients.